NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the NAPLEX with our engaging exam simulation. Our quiz-style format offers multiple-choice questions, hints, and detailed explanations to enhance your learning experience. Get ready to ace your NAPLEX exam!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

For the reduction in risk of major CVD events in CAD/PAD with Rivaroxaban, what is the dosage?

20 mg QD
15 mg BID
10 mg QD
2.5 mg BID

The correct answer is: 2.5 mg BID

The other options are incorrect because they are either too high or too low of a dosage to be effective in reducing the risk of major CVD events in CAD/PAD with Rivaroxaban. Option A, 20 mg QD, is too high and could lead to adverse side effects, while option B, 15 mg BID, may also be too high and BID dosing can be challenging for patients to adhere to. Option C, 10 mg QD, may not be sufficient to effectively reduce the risk. Therefore, option D, 2.5 mg BID, is the recommended dosage for this purpose.